Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multidrug-resistant tuberculosis: this is the cost.

J Moore-Gillon1

  • 1Department of Respiratory Medicine, St. Bartholomew's and Royal London Hospitals, United Kingdom. John@moore-gillon.demon.co.uk

Annals of the New York Academy of Sciences
|January 25, 2002
PubMed
Summary

Multidrug-resistant tuberculosis (MDR TB) incurs significant costs beyond patient treatment. These include expensive public health interventions, prolonged patient care with costlier drugs, and broader economic impacts like lost productivity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rethinking TB screening: politics, practicalities and the press.

Thorax·2010
Same author

An evaluation of the completeness of reporting of childhood tuberculosis.

The European respiratory journal·2009
Same author

Tuberculosis in the United Kingdom and Republic of Ireland.

Archives of disease in childhood·2008
Same author

Tuberculin testing, BCG and tuberculosis today.

Thorax·2005
Same author

Mesothelioma.

Thorax·2002
Same author

Resource implications of patients with multidrug resistant tuberculosis.

Thorax·2000

Area of Science:

  • Public Health
  • Infectious Diseases
  • Health Economics

Background:

  • Multidrug-resistant tuberculosis (MDR TB) presents a significant global health challenge.
  • The emergence of MDR TB necessitates a reevaluation of all tuberculosis (TB) patient management strategies.
  • Controlling the spread of MDR TB requires substantial public health investment.

Purpose of the Study:

  • To analyze the comprehensive economic burden associated with multidrug-resistant tuberculosis.
  • To delineate costs beyond direct clinical treatment for MDR TB patients.
  • To assess the wider societal and economic ramifications of MDR TB.

Main Methods:

  • The study reviews existing literature and cost analyses related to MDR TB treatment and control.
  • It synthesizes data on direct medical costs, including pharmaceuticals and specialized care.

Related Experiment Videos

  • Economic impact assessment incorporates factors like productivity loss and social support.

    • Main Results:

    • MDR TB treatment involves more expensive second-line drugs and extended use of first-line drugs.
    • Public health measures for MDR TB prevention and control are resource-intensive.
    • Increased nursing care and specialized facilities (negative-pressure units) add to treatment expenses.

    Conclusions:

    • The economic impact of MDR TB extends significantly beyond individual patient treatment costs.
    • Societal costs include lost productivity, reduced tax revenue, and family support burdens.
    • Effective MDR TB control strategies must consider these multifaceted economic implications.